Pune, India -- (SBWIRE) -- 05/17/2018 -- The Global cholesterol testing market is expected to reach USD 2,572.27 million by 2025, from USD 1,408.99 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025.

Europe Cholesterol Testing Market is expected to reach USD 2,572.27 million by 2025, from USD 1,408.99 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025.

Click Here for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cholesterol-testing-market

Competitors Analysis:

F. HOFFMANN-LA ROCHE LTD:

Established in 1896 and headquartered at Basel, Switzerland. F. Hoffmann-La Roche Ltd. is one of the largest biotech companies with 17 biopharmaceuticals on the market. Since the establishment in 1896, the company is focused into manufacturing of products for oncology, immunology, ophthalmology, infectious diseases and neuroscience. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., NV Roche SA, Roche SAS, Roche Glycart AG, and Roche Co., Ltd.

SIEMENS AG:

Founded in 1847 and headquartered in Munich, Germany. Siemens is involved in the field of automation, electrification and digitalization. Siemens comprises Siemens AG, a stock corporation under the federal laws of the company and its subsidiaries. The company's operations spans across Europe, Commonwealth of Independent States (C.I.S), Africa, Middle East, Americas, Asia and Australia.
Siemens operates in eight business segments: power and gas, wind power and renewables, energy management, building technologies, mobility, digital factory and process industries and drives and healthineers.

The key market players for Global Cholesterol Testing Market are listed below:

- Abbott Laboratories
- Accutech, LLC
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Prima Lab SA
- Quest Diagnostics, Inc.
- Home Access Health Corporation
- F. Hoffmann-La Roche AG
- Siemens AG
- Sigma-Aldrich Corp.

Request for Detail Report Enquire Click Here @: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cholesterol-testing-market

Market is further segmented into:

- Product Type
- Test
- Test Type
- Prescription Mode
- End-users

The global cholesterol testing market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The Global cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits are expected to dominate the global cholesterol testing market with 58.7% market share and are expected to reach USD 6,119.56 million by 2025, with the highest CAGR of 7.9 % in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile are expected to dominate the global cholesterol testing market with 35.3% market share and are expected to reach USD 3,778.31 million by 2025, with the highest CAGR of 8.3% in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of test type into non-invasive and invasive. The invasive are expected to reach USD 7,131.55 million by 2025, from USD 4,032.26 million in 2017, growing at a CAGR of 7.5%. However, non-invasive is growing at the highest CAGR of 8.2% and is expected to reach USD 3,159.02 million by 2025.

The Global cholesterol testing market is segmented on the basis of prescription mode into over the counter and prescription based. In 2018, prescription-based are expected to dominate the global cholesterol testing market with 76.9% market share and is expected to reach USD 8,059.07 million by 2025, with the highest CAGR of 8.0% in the forecast period 2018 to 2025.

The Global cholesterol testing market is segmented on the basis of prescription mode into end users, clinics, hospitals, ambulatory centers, homecare and diagnostic centers. In 2018, hospitals segment is expected to dominate the global cholesterol testing market with 35.0% market share and is expected to reach USD 4,233.71 million by 2025, with the highest CAGR of 8.5% in the forecast period 2018 to 2025.

Based on geography, the Global cholesterol testing market is segmented into geographical regions, such as,
- North- America,
- South America
- Global
- Asia-Pacific
- Middle East and Africa

Any Quire? Feel Free To Contact Us @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cholesterol-testing-market

Table of Content
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Overview of Global Cholesterol Testing Market
1.4. Currency and Pricing
1.5. Limitation
1.6. Markets Covered
2. Market Segmentation
3. Executive Summary
4. Market Overview
4.1. Drivers ?
4.2. Restraints
4.3. Opportunities
4.4. Challenges
5. Premium Insights
6. Global Cholesterol Testing Market, By Product Type
7. Global Cholesterol Testing Market, By Test
8. Global Cholesterol Testing Market, By Test Type
9. Global Cholesterol Testing Market, By Prescription Mode
10. Global Cholesterol Testing Market, By End-Users
11. Global Cholesterol Testing Market, By Geography
11.1. Overview
11.2. North America
11.3. Europe
11.4. Asia-Pacific
11.5. South America
11.6. Middle East and Africa
12. Global Cholesterol Testing Market, Company Landscape
13. Company Profiles
14. Related Reports

Purchase Full Report of Global Cholesterol Testing Market @ http://databridgemarketresearch.com/reports/global-cholesterol-testing-market/

Related Report

Global Point-Of-Care Diagnostics Market – Industry Trends and Forecast to 2024

Global Point-Of-Care Diagnostics Market By Disease (Diabetes, Cardiac, Coagulation, Cholesterol, Urinary, Blood Gas, Drug Of Abuse, Infectious, Pregnancy & Fertility, Cancer, Hematology, Others), By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-point-of-care-diagnostics-market/

About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com